279 related articles for article (PubMed ID: 32232700)
1. How to resolve confusion in the clinical setting for the diagnosis of heterozygous COL4A3 or COL4A4 gene variants? Discussion and suggestions from nephrologists.
Imafuku A; Nozu K; Sawa N; Nakanishi K; Ubara Y
Clin Exp Nephrol; 2020 Aug; 24(8):651-656. PubMed ID: 32232700
[TBL] [Abstract][Full Text] [Related]
2. Autosomal dominant form of type IV collagen nephropathy exists among patients with hereditary nephritis difficult to diagnose clinicopathologically.
Imafuku A; Nozu K; Sawa N; Hasegawa E; Hiramatsu R; Kawada M; Hoshino J; Tanaka K; Ishii Y; Takaichi K; Fujii T; Ohashi K; Iijima K; Ubara Y
Nephrology (Carlton); 2018 Oct; 23(10):940-947. PubMed ID: 28704582
[TBL] [Abstract][Full Text] [Related]
3. Identification of 47 novel mutations in patients with Alport syndrome and thin basement membrane nephropathy.
Weber S; Strasser K; Rath S; Kittke A; Beicht S; Alberer M; Lange-Sperandio B; Hoyer PF; Benz MR; Ponsel S; Weber LT; Klein HG; Hoefele J
Pediatr Nephrol; 2016 Jun; 31(6):941-55. PubMed ID: 26809805
[TBL] [Abstract][Full Text] [Related]
4. Collagen type IV-related nephropathies in Portugal: pathogenic COL4A3 and COL4A4 mutations and clinical characterization of 25 families.
Nabais Sá MJ; Storey H; Flinter F; Nagel M; Sampaio S; Castro R; Araújo JA; Gaspar MA; Soares C; Oliveira A; Henriques AC; da Costa AG; Abreu CP; Ponce P; Alves R; Pinho L; Silva SE; de Moura CP; Mendonça L; Carvalho F; Pestana M; Alves S; Carvalho F; Oliveira JP
Clin Genet; 2015 Nov; 88(5):456-61. PubMed ID: 25307543
[TBL] [Abstract][Full Text] [Related]
5. Heterozygous Urinary Abnormality-Causing Variants of
Horinouchi T; Yamamura T; Nagano C; Sakakibara N; Ishiko S; Aoto Y; Rossanti R; Nakanishi K; Shima Y; Morisada N; Iijima K; Nozu K
Kidney360; 2020 Sep; 1(9):936-942. PubMed ID: 35369551
[TBL] [Abstract][Full Text] [Related]
6. Thin basement membrane nephropathy.
Savige J; Rana K; Tonna S; Buzza M; Dagher H; Wang YY
Kidney Int; 2003 Oct; 64(4):1169-78. PubMed ID: 12969134
[TBL] [Abstract][Full Text] [Related]
7. COL4A4-related nephropathy caused by a novel mutation in a large consanguineous Saudi family.
Ramzan K; Imtiaz F; Taibah K; Alnufiee S; Akhtar M; Al-Hazzaa SA; Al-Owain M
Int J Pediatr Otorhinolaryngol; 2014 Mar; 78(3):427-32. PubMed ID: 24398087
[TBL] [Abstract][Full Text] [Related]
8. A novel mutation of COL4A3 presents a different contribution to Alport syndrome and thin basement membrane nephropathy.
Hou P; Chen Y; Ding J; Li G; Zhang H
Am J Nephrol; 2007; 27(5):538-44. PubMed ID: 17726307
[TBL] [Abstract][Full Text] [Related]
9. Frequent COL4 mutations in familial microhematuria accompanied by later-onset Alport nephropathy due to focal segmental glomerulosclerosis.
Papazachariou L; Papagregoriou G; Hadjipanagi D; Demosthenous P; Voskarides K; Koutsofti C; Stylianou K; Ioannou P; Xydakis D; Tzanakis I; Papadaki A; Kallivretakis N; Nikolakakis N; Perysinaki G; Gale DP; Diamantopoulos A; Goudas P; Goumenos D; Soloukides A; Boletis I; Melexopoulou C; Georgaki E; Frysira E; Komianou F; Grekas D; Paliouras C; Alivanis P; Vergoulas G; Pierides A; Daphnis E; Deltas C
Clin Genet; 2017 Nov; 92(5):517-527. PubMed ID: 28632965
[TBL] [Abstract][Full Text] [Related]
10. Effect of heterozygous pathogenic COL4A3 or COL4A4 variants on patients with X-linked Alport syndrome.
Zhang Y; Ding J; Zhang H; Yao Y; Xiao H; Wang S; Wang F
Mol Genet Genomic Med; 2019 May; 7(5):e647. PubMed ID: 30883042
[TBL] [Abstract][Full Text] [Related]
11. Clinico-pathological correlations in 127 patients in 11 large pedigrees, segregating one of three heterozygous mutations in the COL4A3/ COL4A4 genes associated with familial haematuria and significant late progression to proteinuria and chronic kidney disease from focal segmental glomerulosclerosis.
Pierides A; Voskarides K; Athanasiou Y; Ioannou K; Damianou L; Arsali M; Zavros M; Pierides M; Vargemezis V; Patsias C; Zouvani I; Elia A; Kyriacou K; Deltas C
Nephrol Dial Transplant; 2009 Sep; 24(9):2721-9. PubMed ID: 19357112
[TBL] [Abstract][Full Text] [Related]
12. Novel heterozygous COL4A3 mutation in a family with late-onset ESRD.
Hoefele J; Lange-Sperandio B; Ruessmann D; Glöckner-Pagel J; Alberer M; Benz MR; Nagel M; Weber LT
Pediatr Nephrol; 2010 Aug; 25(8):1539-42. PubMed ID: 20177710
[TBL] [Abstract][Full Text] [Related]
13. Nine novel COL4A3 and COL4A4 mutations and polymorphisms identified in inherited membrane diseases.
Rana K; Tonna S; Wang YY; Sin L; Lin T; Shaw E; Mookerjee I; Savige J
Pediatr Nephrol; 2007 May; 22(5):652-7. PubMed ID: 17216251
[TBL] [Abstract][Full Text] [Related]
14. COL4A3 mutations and their clinical consequences in thin basement membrane nephropathy (TBMN).
Wang YY; Rana K; Tonna S; Lin T; Sin L; Savige J
Kidney Int; 2004 Mar; 65(3):786-90. PubMed ID: 14871398
[TBL] [Abstract][Full Text] [Related]
15. COL4A3/COL4A4 mutations link familial hematuria and focal segmental glomerulosclerosis. glomerular epithelium destruction via basement membrane thinning?
Voskarides K; Pierides A; Deltas C
Connect Tissue Res; 2008; 49(3):283-8. PubMed ID: 18661361
[TBL] [Abstract][Full Text] [Related]
16. Guidelines for Genetic Testing and Management of Alport Syndrome.
Savige J; Lipska-Zietkiewicz BS; Watson E; Hertz JM; Deltas C; Mari F; Hilbert P; Plevova P; Byers P; Cerkauskaite A; Gregory M; Cerkauskiene R; Ljubanovic DG; Becherucci F; Errichiello C; Massella L; Aiello V; Lennon R; Hopkinson L; Koziell A; Lungu A; Rothe HM; Hoefele J; Zacchia M; Martic TN; Gupta A; van Eerde A; Gear S; Landini S; Palazzo V; Al-Rabadi L; Claes K; Corveleyn A; Van Hoof E; van Geel M; Williams M; Ashton E; Belge H; Ars E; Bierzynska A; Gangemi C; Renieri A; Storey H; Flinter F
Clin J Am Soc Nephrol; 2022 Jan; 17(1):143-154. PubMed ID: 34930753
[TBL] [Abstract][Full Text] [Related]
17. Three Novel Heterozygous COL4A4 Mutations Result in Three Different Collagen Type IV Kidney Disease Phenotypes.
Li A; Gao EZ; Cui YX; Liu JH; Lv X; Wei XX; Xia XY; Gao CL; Liu FX; Xia ZK; Asan ; Liu ZH; Li XJ
Cytogenet Genome Res; 2018; 154(1):30-36. PubMed ID: 29669314
[TBL] [Abstract][Full Text] [Related]
18. Mutation Analysis of Thin Basement Membrane Nephropathy.
Hirabayashi Y; Katayama K; Mori M; Matsuo H; Fujimoto M; Joh K; Murata T; Ito M; Dohi K
Genes (Basel); 2022 Oct; 13(10):. PubMed ID: 36292665
[TBL] [Abstract][Full Text] [Related]
19. COL4A3/COL4A4 mutations: from familial hematuria to autosomal-dominant or recessive Alport syndrome.
Longo I; Porcedda P; Mari F; Giachino D; Meloni I; Deplano C; Brusco A; Bosio M; Massella L; Lavoratti G; Roccatello D; Frascá G; Mazzucco G; Muda AO; Conti M; Fasciolo F; Arrondel C; Heidet L; Renieri A; De Marchi M
Kidney Int; 2002 Jun; 61(6):1947-56. PubMed ID: 12028435
[TBL] [Abstract][Full Text] [Related]
20. Alport syndrome and thin basement membrane nephropathy.
Thorner PS
Nephron Clin Pract; 2007; 106(2):c82-8. PubMed ID: 17570934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
